331 Spam-Free Article(s) Found
Sort:
Relevance
Like
Date
Filter:
7d
All
DeepLinks
Article Searches
Wall Street Analysts See a 56.18% Upside in Morphic Holding, Inc. (MORF): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2231768/wall-street-analysts-see-a-56-18-upside-in-morphic-holding-inc-morf-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2231768 Feb 26, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 56.2% in Morphic Holding, Inc. (MORF). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts See a 131.6% Upside in Relay Therapeutics, Inc. (RLAY): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2231767/wall-street-analysts-see-a-131-6-upside-in-relay-therapeutics-inc-rlay-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2231767 Feb 26, 2024 - The mean of analysts' price targets for Relay Therapeutics, Inc. (RLAY) points to a 131.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts See a 70.57% Upside in Replimune Group, Inc. (REPL): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2230991/wall-street-analysts-see-a-70-57-upside-in-replimune-group-inc-repl-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2230991 Feb 23, 2024 - The consensus price target hints at a 70.6% upside potential for Replimune Group, Inc. (REPL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts See a 30.21% Upside in Arvinas, Inc. (ARVN): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2230992/wall-street-analysts-see-a-30-21-upside-in-arvinas-inc-arvn-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2230992 Feb 23, 2024 - The consensus price target hints at a 30.2% upside potential for Arvinas, Inc. (ARVN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts See an 185.54% Upside in Intellia Therapeutics, Inc. (NTLA): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2230995/wall-street-analysts-see-an-185-54-upside-in-intellia-therapeutics-inc-ntla-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2230995 Feb 23, 2024 - The consensus price target hints at an 185.5% upside potential for Intellia Therapeutics, Inc. (NTLA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts See Snowflake Inc. (SNOW) as a Buy: Should You Invest? https://www.zacks.com/stock/news/2230882/wall-street-analysts-see-snowflake-inc-snow-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2230882 Feb 23, 2024 - The average brokerage recommendation (ABR) for Snowflake Inc. (SNOW) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Sealed Air (SEE) to Report Q4 Earnings: What to Expect? https://www.zacks.com/stock/news/2230384/sealed-air-see-to-report-q4-earnings-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2230384 Feb 22, 2024 - Sealed Air's (SEE) Q4 results are likely to bear lower volumes, owing to recessionary pressures in the industrial and fulfillment market, and food market declines.
Wall Street Analysts See a 25.37% Upside in Atmus Filtration (ATMU): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2230213/wall-street-analysts-see-a-25-37-upside-in-atmus-filtration-atmu-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2230213 Feb 22, 2024 - The consensus price target hints at a 25.4% upside potential for Atmus Filtration (ATMU). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
FTI Consulting Q4 Profit Climbs, Tops Estimates; Sees Higher FY24 Results; Stock Up In Pre-market https://www.rttnews.com/story.aspx?Id=3426693 Feb 22, 2024 - FTI Consulting, Inc. (FCN) reported Thursday that its fourth-quarter net income climbed to $81.6 million from last year's $47.5 million.
Gold Royalty: Market Sees U-Turn, But Better With Lower Prices https://seekingalpha.com/article/4672250-gold-royalty-market-sees-u-turn-but-better-with-lower-prices?source=feed_all_articles Feb 21, 2024 - Gold Royalty is poised to gain from the upcoming gold price surge in 2024, with promising financial improvements hinting at profitable growth ahead. See more here.

Pages: 1...1415161718192021222324...34

<<<Page 19>